PEGylated anti-fibroblast growth factor 2 aptamer (Ribomic)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePEGylated anti-fibroblast growth factor 2 aptamer (Ribomic)
Drug Alias NameAPT-F2P
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionFibroblast growth factor 2 inhibitors
TargetsFibroblast growth factor 2
Therapy Area/IndicationsPainBone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRibomic Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRibomic Inc
Active IndicationsN/A
Inactive IndicationsPainBone Diseases

Other Information

ATC CodeN/A
Related LinksN/A